Litcius/Paper detail

Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials

Hannah L. Williams, Emmanouil Fokas, Markus Diefenhardt, Calvin Lee, F.S. Verheij, D.M. Omer, S. T. Lin, Richard F. Dunne, Jorge Marcet, Peter A. Cataldo, Blasé N. Polite, Pompiliu Piso, Bülent Polat, Hendrik Dapper, Maryam Ghadimi, R. D. Hofheinz, Li‐Xuan Qin, Leonard B. Saltz, Abraham J. Wu, Marc J. Gollub, J. Joshua Smith, Martin R. Weiser, Claus Rödel, Julio García‐Aguilar

2025Annals of Oncology37 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTotal mesorectal excisionRandomized controlled trialNeoadjuvant therapyInternal medicineOncologySurgeryColorectal cancerCancerBreast cancerColorectal Cancer Surgical TreatmentsColorectal and Anal CarcinomasEsophageal Cancer Research and Treatment
Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials | Litcius